Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
167.9 USD | +0.07% | +1.31% | +7.64% |
05:07pm | AbbVie Says Rinvoq Shows Superiority Versus Dupixent in Atopic Dermatitis Trial Primary Endpoint | MT |
12:11pm | Scholz promises support for pharma sector in Germany as Merck invests | RE |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.